COVID-19 Research Paper Volume 13, Issue 2 pp 1591—1607

Coagulation dysfunction in ICU patients with coronavirus disease 2019 in Wuhan, China: a retrospective observational study of 75 fatal cases

Changes in functional coagulation laboratory markers in ICU patients with critical type COVID-19. Percentage of patients with abnormalities in various coagulation markers. ICU: intensive care unit; COVID-19: coronavirus disease 2019. FDP: fibrinogen degradation products; Fbg: fibrinogen; PT: prothrombin time; PTA: PT activity; TT: thromboplastin time; APTT: activated partial TT; AT-III: antithrombin III.

Figure 1. Changes in functional coagulation laboratory markers in ICU patients with critical type COVID-19. Percentage of patients with abnormalities in various coagulation markers. ICU: intensive care unit; COVID-19: coronavirus disease 2019. FDP: fibrinogen degradation products; Fbg: fibrinogen; PT: prothrombin time; PTA: PT activity; TT: thromboplastin time; APTT: activated partial TT; AT-III: antithrombin III.